Artgen Biotech PJSC (MIC:ABIO) Other Operating Expense : ₽614 Mil (TTM As of Jun. 2023)

View and export this data going back to 2006. Start your Free Trial

What is Artgen Biotech PJSC Other Operating Expense?

Artgen Biotech PJSC's Other Operating Expense for the six months ended in Jun. 2023 was ₽333 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2023 was ₽614 Mil.

Artgen Biotech PJSC's quarterly Other Operating Expense declined from Jun. 2022 (₽316 Mil) to Dec. 2022 (₽281 Mil) but then increased from Dec. 2022 (₽281 Mil) to Jun. 2023 (₽333 Mil).

Artgen Biotech PJSC's annual Other Operating Expense increased from Dec. 2020 (₽558 Mil) to Dec. 2021 (₽695 Mil) but then declined from Dec. 2021 (₽695 Mil) to Dec. 2022 (₽597 Mil).

Artgen Biotech PJSC Other Operating Expense Historical Data

The historical data trend for Artgen Biotech PJSC's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Artgen Biotech PJSC Other Operating Expense Chart

Artgen Biotech PJSC Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Other Operating Expense

Get a 7-Day Free Trial

377.51

400.22

558.37

695.10

596.81

Artgen Biotech PJSC Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Other Operating Expense	Get a 7-Day Free Trial															361.94	333.17	315.57	281.24	332.88

Artgen Biotech PJSC Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₽614 Mil.

Artgen Biotech PJSC Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Artgen Biotech PJSC's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Artgen Biotech PJSC (MIC:ABIO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Artgen Biotech PJSC (MIC:ABIO) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Prospect of the 60th Anniversary, Moscow, RUS, 117036

Website

https://www.hsci.ru

Artgen Biotech PJSC formerly Human Stem Cells Institute PJSC is a biotechnology company. It is engaged in the drug discovery, research and development and marketing of proprietary products and services in the field of regenerative medicine, bio-insurance, medical genetics, including reproductive genetics, gene therapy, and biopharmaceutics. The company has developed Neovasculgen, which is a gene therapy drug for the treatment of Peripheral Arterial Disease, including Critical Limb Ischemia and also develops SPRS therapy which entails the use of autologous dermal fibroblasts to repair skin damage due to aging and other structural changes.